Abstract 13825: Clinical and Echocardiographic Outcomes Associated With Early Initiation of Beta Blockers Use Among Patients With Recently Diagnosed Non-Ischemic Cardiomyopathy Treated With a Wearable Cardioverter Defibrillator

Authors

Ido Goldenberg, University of Rochester Medical Center, Rochester, NY
Moghniuddin Mohammed, Rochester Regional HealthFollow
Mehmet K. Aktas, University of Rochester Medical Center, Rochester, NY
Wojciech Zareba, University of Rochester Medical Center, Rochester, NY
Scott McNitt, University of Rochester Medical Center, Rochester, NY
Valentina Kutyifa, University of Rochester, Rochester, NY

Department

Cardiology

Document Type

Conference Proceeding

Publication Title

Circulation

Conference Name

American Heart Association Scientific Sessions

Conference Date

2022-11-05 - 2022-11-07

First Page

A13825

DOI

10.1161/circ.146.suppl_1.13825

Volume

146

Issue

Suppl_1

Publication Date

11-8-2022

Comments

ELECTROPHYSIOLOGY AND ARRHYTHMIAS

SESSION TITLE: NOVEL RESEARCH INTO ARRHYTHMIA RISK STRATIFICATION

Recommended Citation

Goldenberg, I., Mohammed, M., Aktas, M. K., Zareba, W., McNitt, S., & Kutyifa, V. (2022). Abstract 13825: Clinical and Echocardiographic Outcomes Associated With Early Initiation of Beta Blockers Use Among Patients With Recently Diagnosed Non-Ischemic Cardiomyopathy Treated With a Wearable Cardioverter Defibrillator. Circulation, 146 (Suppl_1), A13825. https://doi.org/10.1161/circ.146.suppl_1.13825